Clinical Trials Directory

Trials / Completed

CompletedNCT00232245

Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atrial Fibrillation.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Melbourne Health · Academic / Other
Sex
All
Age
18 Years – 88 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate whether fish oil supplements may reduce the frequency and duration of paroxysmal atrial fibrillation episodes. Atrial fibrillation is a heart condition which effects a large percentage of the population . Atrial fibrillation is a condition frequently experienced by people who have had pacemakers inserted . Certain Pacemakers have sophisticated monitoring features that are able to recognise episodes of atrial fibrillation. Fish oil supplements may be of benefit to patients with heart problems.Recent evidence suggests that fish oils may be beneficial to patients with rhythm disturbances. By interrogating pacemakers this study will investigate the effect of fish oil supplements on the frequency and duration of episodes of atrial fibrillation.

Conditions

Interventions

TypeNameDescription
DRUGFish oil

Timeline

Start date
2003-12-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2005-10-04
Last updated
2013-05-30

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT00232245. Inclusion in this directory is not an endorsement.

Use of Fish Oils to Reduce the Frequency and Duration of Episodes of Atrial Fibrillation in Patients With Paroxysmal Atr (NCT00232245) · Clinical Trials Directory